Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
about
Mitochondrial dysfunction in inflammatory bowel diseaseOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesImmunosuppression associated with chronic inflammation in the tumor microenvironmentInhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donorsExpression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.In situ generation of nitric oxide by myenteric neurons but not by mononuclear cells of the human colon.Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats.eNOS involved in colitis-induced mucosal blood flow increase.Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.Ibuprofen augments gastrointestinal symptoms in lactose maldigesters during a lactose tolerance test.Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders.Chronic inflammation and cytokines in the tumor microenvironment.Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB.Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.Peroxynitrite and inflammatory bowel diseaseProhibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells.Plasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease.Nitric oxide-induced cellular stress and p53 activation in chronic inflammationSmall therapeutic molecules for the treatment of inflammatory bowel diseaseColorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.Activated eosinophils in association with enteric nerves in inflammatory bowel disease.Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis.Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitisChemistry meets biology in colitis-associated carcinogenesisProtection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice.Colitis generates remote antinociception in rats: the role of the L-arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems.Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.Nitric oxide synthesis in patients with infective gastroenteritisThe physiological expression of inducible nitric oxide synthase (iNOS) in the human colonIncreases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.Diminished nitroprusside-induced relaxation of inflamed colonic smooth muscle in micePegylated arginine deiminase downregulates colitis in murine models.The role and therapeutic potential of prohibitin in disease.Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammationAnti-inflammatory effect of Pycnocycla spinosa extract and its component isoacetovanillone on acetic acid induced colitis in rats.A Combination of Podophyllotoxin and Rutin Attenuates Radiation Induced Gastrointestinal Injury by Negatively Regulating NF-κB/p53 Signaling in Lethally Irradiated Mice.Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitisTumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences.
P2860
Q26781311-2172529C-5DE6-4578-B8EC-36AD6925D1B9Q28069372-CEB2B8DB-0594-4830-870D-3E79DF2CE443Q28083450-42238420-774D-4170-954F-BC10563863E9Q28344914-5647AAD4-CB6A-41F3-9AD6-4B54E2896F20Q30322266-7E588A6C-8C2B-4FA2-A6F7-1525DAD810C1Q31818093-11758365-547D-4156-9329-63F3CBDEF7A0Q31818190-8A0E5514-30B5-474A-8B2B-7A8542C4210EQ33303154-3535DDA2-0324-46D3-ABFB-07A72782A876Q33340603-D5B1D213-2FFC-481B-833A-FC84984A6905Q33420984-CD15178D-66B4-4F66-8480-6020650288B2Q33548209-280F4313-F362-4218-B090-62DBCE40E64EQ33678275-203F4CA1-B015-45CB-9384-C22CA4407877Q33738101-D9BE6FF7-DCBA-4996-A04F-20B316E5D719Q33785337-8D3F03EA-1680-4917-90C1-B3DB3ABD7805Q33836818-B63E4F67-A8C3-46A5-9489-1FFBBFD520ACQ34170657-71515ABA-F3DB-4198-BCD1-E8E2A8772056Q34410349-FC9EE755-2050-4F23-BC73-FF5D1C95D6D0Q34466925-1DF0A3FC-E3FE-4368-91C5-1DD1A03C33DFQ34600992-A2DD3E9B-88B6-40E5-BD25-E477CA2408C4Q34663857-F1A5C637-169C-4DA0-A858-BF443AF40433Q34745442-544C90B3-0B77-4E54-949E-F6E4796D6C8BQ35044303-C712B069-2103-4F92-82AD-4A63E86F5EBEQ35045291-F204AE73-9161-4C0E-A868-B25BB5A5365DQ35047726-4756C45B-5007-44A5-8C4C-A4C5C44B126AQ35119930-A39CC5CB-6E70-43A9-A467-274EDD3D0C89Q35257531-94505D9C-5FC2-4461-AEF3-F34EC6C9F8ADQ35305940-4A75129A-CCC2-4112-9B10-8C68DD3E9CC8Q35349431-3457980D-1528-4C82-BE59-92A965809DDCQ35356639-5F7E486A-2C05-4FE9-990E-D0AEB3A6A420Q35398520-7119A45A-11B8-4BB4-91DD-F8D595962E15Q35595658-A86FBFDC-AC8F-4A42-B937-748C27FD0E42Q35609860-4DCB47D1-1827-44CB-B5D5-506ADCAD44C3Q35725419-8003FC1F-610B-4C0A-9428-8E3BB5155FFFQ36018450-829A3035-6254-4930-823A-64887239456EQ36114938-50445D90-6911-4E9D-B980-D10E1F0480B4Q36216736-2D4B0B1F-3B9E-4E96-BCA6-C78515A15192Q36236345-3BFF572A-A61E-4DBF-9486-4F596FB7EDF4Q36355121-F2683540-6D83-4F80-AB14-30003C462DFCQ36585724-AA2E1749-01BC-4788-A791-D4E225155E52Q36674023-8E6A4F16-06FB-4819-80BC-05B0222480A6
P2860
Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@ast
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@en
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@nl
type
label
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@ast
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@en
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@nl
prefLabel
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@ast
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@en
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@nl
P2093
P2860
P356
P1433
P1476
Enhanced colonic nitric oxide ...... e colitis and Crohn's disease.
@en
P2093
D Bachwich
D K Podolsky
D Rachmilewitz
J S Stamler
Z Ackerman
P2860
P304
P356
10.1136/GUT.36.5.718
P407
P577
1995-05-01T00:00:00Z